MedTrace Logo

Comparative Effectiveness of Adding Weight Control to Smoking Cessation Quitlines

NCT01867983 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2540

Last updated 2016-04-15

No results posted yet for this study

Summary

This randomized controlled trial compares the effectiveness for both smoking cessation and weight control of two alternative combined interventions offered via telephone quitline, as compared to standard of care quitline treatment addressing cessation alone. The interventions to be compared are cessation treatment alone versus cessation treatment combined with weight control treatment added either simultaneously or sequentially.

Conditions

Interventions

BEHAVIORAL

Weight gain prevention and smoking cessation

The two intervention groups will receive weight gain prevention either: Simultaneous: weight control treatment simultaneous with cessation treatment (5 proactive calls with a quit coach combined with weight coach/nutritionist followed by 5 'contact control calls'), or Sequential: weight control treatment added after cessation treatment (5 proactive calls with a quit coach followed by 5 weight coach/nutritionist calls). All three study arms will include a total of 10 phone counseling calls, interactive web, mailed support materials, access to nicotine replacement therapy (NRT) and unlimited participant initiated calls.

BEHAVIORAL

Smoking cessation

The control group will receive cessation treatment calls (5 proactive calls with a quit coach followed by 5 contact control calls.

Sponsors & Collaborators

  • SRI International

    collaborator INDUSTRY

  • Northwestern University

    collaborator OTHER

  • Consumer Wellness Solutions

    lead INDUSTRY

Principal Investigators

  • Terry Bush, PHD · Consumer Wellness Solutions

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01867983 on ClinicalTrials.gov